Tiffiny S. Cooper

Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells

Somaira Nowsheen, Tiffiny S. Cooper, Jennifer Stanley et al. · PLoS ONE · 2012 · 111 citations · Full text

Breast Oncology, Parp Inhibition, Synthetic Lethal Interactions +14

DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma

Alice N. Weaver, Tiffiny S. Cooper, M. Rodriguez et al. · Oncotarget · 2015 · 78 citations · Full text

HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

Somaira Nowsheen, Tiffiny S. Cooper, James A. Bonner et al. · Cancer Research · 2012 · 75 citations · Full text

Breast Oncology, Molecular Biology, Any Defect +20

Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances <i>In Vitro</i> and <i>In Vivo</i> Cytotoxicity in Head and Neck Squamous Cell Carcinoma

Ling Zeng, Reena R. Beggs, Tiffiny S. Cooper et al. · Molecular Cancer Therapeutics · 2017 · 54 citations · Full text

Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity

Alice N. Weaver, M. Benjamin Burch, Tiffiny S. Cooper et al. · Molecular Cancer Research · 2016 · 39 citations · Full text